Semaglutide dosage at a glance
- Semaglutide is a long‑acting GLP‑1 analogue used as a weekly injection (Ozempic, Wegovy) or a daily tablet (Rybelsus).
- Doses are increased gradually (titrated) to improve tolerability and reduce stomach‑related side effects.
- Weight loss maintenance doses are often higher (Wegovy up to 2.4 mg weekly) than type 2 diabetes doses (Ozempic commonly 0.5–1 mg, up to 2 mg weekly where indicated).
- Compounded semaglutide vial strengths vary. Milligram and mL labels are not interchangeable—always confirm the concentration before measuring a dose.
- Missed‑dose rules are brand specific. Check your Consumer Medicine Information (CMI) and speak to your prescriber.
Approved forms and brand names
In Australia, semaglutide is available as:
- Ozempic (semaglutide) weekly injection for type 2 diabetes; some clinicians also use it in weight management where clinically appropriate.
- Wegovy (semaglutide) weekly injection specifically indicated for chronic weight management at higher maintenance doses.
- Rybelsus (oral semaglutide) daily tablet in selected markets; Australian availability and funding can differ over time. See our Rybelsus page for current status.
You may also see compounded semaglutide offered by some pharmacies or clinics. These products are not the same as TGA‑approved brands and can vary in concentration, excipients and quality controls. Dosing instructions are not interchangeable with branded pens.
Learn more: What Is Semaglutide? · GLP‑1 Australia Guide · Is Semaglutide Legal in Australia?
Weekly injection titration: Ozempic and Wegovy
Titration helps limit nausea and other gastrointestinal effects by increasing the dose in steps. Your prescriber may adjust the pace depending on your response.
Typical Ozempic titration for type 2 diabetes
- Weeks 1–4: 0.25 mg once weekly (a start‑up dose; not intended for glycaemic control)
- Weeks 5–8: 0.5 mg once weekly
- Maintenance: 0.5–1 mg once weekly; some patients may be escalated to 2 mg once weekly
Typical Wegovy titration for weight management
- Weeks 1–4: 0.25 mg once weekly
- Weeks 5–8: 0.5 mg once weekly
- Weeks 9–12: 1.0 mg once weekly
- Weeks 13–16: 1.7 mg once weekly
- Maintenance: 2.4 mg once weekly as tolerated; some remain at 1.7 mg if side effects persist
These are label‑based patterns. The right step and maintenance dose is individual—based on tolerability, efficacy, comorbidities and other medicines.
Daily tablet dosing: Rybelsus (oral semaglutide)
- Start: 3 mg once daily for 30 days
- Then increase to 7 mg once daily
- Consider 14 mg once daily if additional effect is needed and tolerated
Administer Rybelsus on an empty stomach with a small amount of water, and wait before eating or taking other oral medicines (see CMI for brand‑specific timing). Because semaglutide delays gastric emptying, discuss any medicines with a narrow therapeutic index with your prescriber.
More detail: Rybelsus Australia Guide · Rybelsus vs Ozempic
Dosing for weight loss vs diabetes control
- Diabetes (Ozempic): Many patients remain at 0.5–1 mg weekly; some require 2 mg for additional glycaemic effect.
- Weight management (Wegovy): The labelled maintenance target is 2.4 mg weekly as tolerated; some patients remain at 1.7 mg if needed.
Higher doses often improve appetite suppression but can increase side effects. Dose choice balances benefit, tolerability, and clinical goals. Lifestyle changes remain essential at every dose.
Related: Semaglutide for Weight Loss · Results Timeline · Benefits
Missed‑dose guidance (check your brand’s CMI)
- Weekly pens: Labels provide a “catch‑up” window measured in days. If you are outside that window, skip the missed dose and take your next dose on the usual day. If multiple doses are missed, your prescriber may re‑start at a lower step to reduce side effects.
- Daily tablets: If you miss a dose and remember later the same day, take it as soon as you remember. If it’s the next day, skip the missed dose—do not double up.
The exact window differs between brands and markets. Always follow your pen’s on‑pack instructions and speak to your prescriber or pharmacist if unsure.
Compounded vials vs pens: reading dose and strength
With branded pens, the dose is selected on the device. With compounded semaglutide, you may receive a vial with a concentration such as “5 mg/mL” or “2.5 mg/mL.” The same dose in milligrams can correspond to different syringe volumes depending on the concentration.
- Always confirm the vial’s concentration (mg per mL) and the prescribed dose (mg per injection).
- Clarify the syringe units (e.g., 0.01 mL per tick on an insulin syringe) before your first dose.
- Do not assume another person’s protocol or volume matches your product strength.
If measurements are unclear, pause and contact your clinic or pharmacist. Accurate measurement prevents under‑ or over‑dosing.
Helpful: Peptide Injection Guide · Buy Semaglutide Australia
Safety, contraindications and cautions
- Do not use if you or a family member has a history of medullary thyroid carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
- Pancreatitis: Stop and seek urgent care if you develop severe, persistent abdominal pain (with or without vomiting). A history of pancreatitis warrants extra caution.
- Gallbladder disease: Rapid weight loss and GLP‑1 RAs can increase gallstone risk. Report upper‑right abdominal pain or jaundice.
- Diabetic retinopathy: Rapid glucose improvements may transiently worsen retinopathy in susceptible patients—ensure eye monitoring if at risk.
- Kidney function: Severe vomiting/diarrhoea can precipitate dehydration and acute kidney injury. Maintain fluids and seek care if unwell.
- Pregnancy and breastfeeding: Not recommended. Discuss contraception and planning with your prescriber.
- Drug interactions: Reduced appetite and delayed gastric emptying can affect absorption of some oral medicines. Take care with insulin/sulfonylureas to avoid hypoglycaemia.
- Renal/hepatic impairment: No routine dose adjustment is typically required, but clinical monitoring is advised.
Read next: Semaglutide Side Effects
Practical use: injection sites, timing and food
- Injection sites: Abdomen, thigh, or upper arm (subcutaneous). Rotate sites to reduce irritation.
- Timing: Pick any day of the week for injections and stick to it. Tablets are taken daily on an empty stomach as per label.
- Alcohol and large meals: Heavy meals and alcohol can worsen nausea, especially during titration.
- Plateaus: Plateaus are common; increasing the dose is not always the answer. Diet quality, protein intake, resistance training and sleep support outcomes.
Explore: Weight Loss Injections Australia · Semaglutide vs Tirzepatide
Storage, travel and handling
- Refrigeration: Unopened pens are typically stored at 2–8°C. Do not freeze. If frozen, do not use.
- In‑use pens: Many brands allow room‑temperature storage for a limited period (often up to several weeks). Check your pen’s specific in‑use window.
- Light and heat: Protect from sunlight. Avoid leaving pens in hot cars or luggage holds.
- Travel: Use a cooled pouch for long trips. Carry spares and alcohol swabs. Keep medicines in original packaging for customs.
- Compounded vials: Follow the pharmacy label exactly; storage rules can differ from branded pens.
Get personalised semaglutide guidance
Send your questions about dosing, brand differences, titration pace, or compounded strengths. We are an information resource and can help you understand your options or connect you with legitimate providers.
If you are experiencing severe symptoms (e.g., signs of pancreatitis or allergic reaction), seek urgent medical care.
Frequently asked questions
What is the usual starting dose for semaglutide injections?
Most protocols start at 0.25 mg once weekly for 4 weeks to improve tolerability before stepping up.
What is the typical maintenance dose?
For diabetes, many patients remain at 0.5–1 mg weekly (some use 2 mg). For weight management, Wegovy targets 2.4 mg weekly if tolerated.
How long should I stay at each titration step?
Often 4 weeks per step. Your clinician may extend a step if side effects are troublesome or move sooner based on response.
Can I switch between Ozempic and Wegovy at the same dose?
They contain the same active ingredient but different pens, indications, and labelled dose ranges. Switching should be clinician‑directed to ensure dose equivalence and safety.
Do I need a dose change with kidney or liver issues?
Routine dose adjustment is not usually required, but clinical monitoring is recommended. Discuss your history with your prescriber.
How do I measure a compounded dose correctly?
Confirm the vial concentration (mg/mL) and your target dose (mg). Your clinic should translate this into an exact syringe volume and demonstrate technique before you start.
What if I miss a weekly dose?
Follow the brand‑specific instructions in your CMI. Weekly products provide a defined window for catch‑up; otherwise skip and resume on your usual day.
Where can I read more?
See Semaglutide Side Effects, Results Timeline, Semaglutide Cost Australia, and Prescription in Australia.
Final takeaway
Semaglutide dosing depends on your indication, product form, tolerability and goals. Start low, step gradually, and confirm any change with your prescriber—especially if you use compounded vials with different strengths.
For next steps, compare brands, read side effects and timelines, and speak with a qualified provider.